EquityFlowCompanies › Neurophet

Neurophet

Healthtech · Seoul, KR

Brain-imaging AI solution for Alzheimer's and related dementia.

Funding history

DateRoundAmount
Nov 2023Funding round
Brain-imaging AI company Neurophet raised KRW 20B.
$15M
Nov 2021Funding round
Neurophet, a Korean brain-disease AI company, raised KRW 19B to advance dementia-diagnosis technology and global clinical trials.

Similar companies in Healthtech

Explore funding flow on EquityFlow →